Wednesday, November 30, 2016
3:00 pm EST (12:00 pm PST)
Before therapies can become available to the public, they must first be tested in clinical trials. What’s preventing individuals with HBV from participating in clinical trials?
Where can healthcare providers find clinical trials appropriate for their patients with HBV?
What key messages about new therapies and clinical trials should community partners include in their outreach programs?
Please join Hep B United and the Hepatitis B Foundation to learn about strategies to motivate individuals with hepatitis B and their providers to participate in clinical trials.